🇺🇸 long acting injectable risperidone, Conventional Dose Group in United States

long acting injectable risperidone, Conventional Dose Group (long acting injectable risperidone, Conventional Dose Group) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

long acting injectable risperidone, Conventional Dose Group in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is long acting injectable risperidone, Conventional Dose Group approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for long acting injectable risperidone, Conventional Dose Group in United States?

Northwestern University is the originator. The local marketing authorisation holder may differ — check the official source linked above.